- Home
- RGNX vs EVN Comparison
RGNX vs EVN Comparison
Compare RGNX & EVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- EVN
- Stock Information
- Founded
- RGNX 2008
- EVN 1998
- Country
- RGNX United States
- EVN United States
- Employees
- RGNX N/A
- EVN N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- EVN Investment Bankers/Brokers/Service
- Sector
- RGNX Health Care
- EVN Finance
- Exchange
- RGNX Nasdaq
- EVN Nasdaq
- Market Cap
- RGNX 356.7M
- EVN 418.1M
- IPO Year
- RGNX 2015
- EVN N/A
- Fundamental
- Price
- RGNX $7.27
- EVN $10.72
- Analyst Decision
- RGNX Buy
- EVN
- Analyst Count
- RGNX 12
- EVN 0
- Target Price
- RGNX $33.36
- EVN N/A
- AVG Volume (30 Days)
- RGNX 698.7K
- EVN 101.2K
- Earning Date
- RGNX 02-28-2025
- EVN 01-01-0001
- Dividend Yield
- RGNX N/A
- EVN 4.78%
- EPS Growth
- RGNX N/A
- EVN N/A
- EPS
- RGNX N/A
- EVN 0.34
- Revenue
- RGNX $84,327,000.00
- EVN N/A
- Revenue This Year
- RGNX $2.23
- EVN N/A
- Revenue Next Year
- RGNX $250.77
- EVN N/A
- P/E Ratio
- RGNX N/A
- EVN $29.94
- Revenue Growth
- RGNX N/A
- EVN N/A
- 52 Week Low
- RGNX $6.56
- EVN $8.64
- 52 Week High
- RGNX $28.80
- EVN $10.45
- Technical
- Relative Strength Index (RSI)
- RGNX 41.90
- EVN 67.75
- Support Level
- RGNX $6.92
- EVN $10.60
- Resistance Level
- RGNX $7.79
- EVN $10.75
- Average True Range (ATR)
- RGNX 0.44
- EVN 0.09
- MACD
- RGNX -0.04
- EVN 0.02
- Stochastic Oscillator
- RGNX 19.40
- EVN 93.48
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About EVN Eaton Vance Municipal Income Trust
Eaton Vance Municipal Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax. The trust's portfolio of investments majorly consists of debt instruments of governments, municipal organizations the interest on which is exempt from regular federal income tax and has also some exposure to corporate bonds and other instruments.